Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
South Australian Health And Medical Research Institute Limited maintains a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action. This specific matter is assigned to 1 distinct examiner, VOLKOV, ALEXANDER ALEXANDROVIC. The prosecution footprint is limited to 1 distinct art unit, reflecting a concentrated examination environment. VOLKOV, ALEXANDER ALEXANDROVIC serves as the busiest examiner for the company, with 1 busiest examiner pending office action.
This alignment between the 1 pending office action and the busiest examiner's workload confirms that all current USPTO engagement is managed by a single individual. For a patent practitioner, this concentration suggests that the outcome of the current portfolio activity depends entirely on the interpretation of 1 distinct examiner within 1 distinct art unit. The Biotechnology & Pharmaceuticals focus remains consistent across this singular point of contact. This lack of examiner diversity requires a highly tailored approach to the specific preferences of the assigned official. Practitioners should prepare for a focused dialogue within this specific art unit to advance the pending matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VOLKOV, ALEXANDER ALEXANDROVIC | 1 | 29.5% | +21.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17637494 | Methods and Products for Assessing Lysosomal System Flux | VOLKOV, ALEXANDER ALEXANDROVIC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17637494 | Methods and Products for Assessing Lysosomal System Flux | VOLKOV, ALEXANDER ALEXANDROVIC | — |
| Art Unit | Apps |
|---|---|
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17637494 | Methods and Products for Assessing Lysosomal System Flux | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | §101§103§112 | Non-Final OA | — | Pending | Feb 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSouth Australian Health And Medical Research Institute Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Alexander Alexandrovic Volkov has the most, with 1 of South Australian Health And Medical Research Institute Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
